Fate Therapeutics
(NASDAQ:FATE)
$7.00
-0.04[-0.57%]
At close: Mar 18
$7.00
0[0.00%]
PreMarket: 7:20PM EDT

GET A REPORT ON FATE SENT RIGHT TO YOUR INBOX

50%
Overview Rating
Speculative
Technicals Analysis
100
0100
Financials Analysis
20
0100

Fate Therapeutics Stock (NASDAQ:FATE), Quotes and News Summary

Fate Therapeutics Stock (NASDAQ: FATE) stock price, news, charts, stock research, profile.
Open-
Close-
Volume / Avg.2.000 / 2.873M
Day Range- - -
52 Wk Range1.630 - 8.830
Market Cap$694.663M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
49
Short Interest
17.16%
Days to Cover4.16
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Nov 23
1
4
Feb
1
3
Strong Buy
Buy
Hold
Sell
Strong Sell
About Fate Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It i...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
FATE
CABA

FAQ

Q

How do I buy Fate Therapeutics (FATE) stock?

A

You can purchase shares of Fate Therapeutics (NASDAQ: FATE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Fate Therapeutics's (FATE) competitors?

Q

What is the target price for Fate Therapeutics (FATE) stock?

A

The latest price target for Fate Therapeutics (NASDAQ: FATE) was reported by Morgan Stanley on Tuesday, February 27, 2024. The analyst firm set a price target for 7.00 expecting FATE to fall to within 12 months (a possible 0.00% downside). 20 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Fate Therapeutics (FATE)?

A

The stock price for Fate Therapeutics (NASDAQ: FATE) is $7 last updated March 18, 2024 at 7:20 PM EDT.

Q

Does Fate Therapeutics (FATE) pay a dividend?

A

There are no upcoming dividends for Fate Therapeutics.

Q

When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?

A

Fate Therapeutics’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Q

Is Fate Therapeutics (FATE) going to split?

A

There is no upcoming split for Fate Therapeutics.

Q

What sector and industry does Fate Therapeutics (FATE) operate in?

A

Fate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch